|*DISCLAIMER: This page is an unmoderated forum, and the opinions expressed herein do not necessarily reflect the viewpoint of The Johns Hopkins Medical Institutions. Patients are advised to consult their personal physicians before making any medical decisions. |
If my mom was still eligible for this trial, I would be urging her to try it. I think the GVAX Pancreas Vaccine/CRS-207 arm makes it attractive enough to try, but the 2nd arm adds Nivolumab to the GVAX and CRS-207. Unfortunately, the study is written so you can have only failed 1 type of chemotherapy and my mom has exhausted both Folfirinox and Gemcitabine/Abraxane.
I urge any of you that are on your first type of chemotherapy to try this
study if/when the time becomes appropriate. Anything that you can do to
potentially buy some time for you or your loved one is worth a shot, and I
think this trial could potentially be the future of treatment.
Reply to this message | Return to Main Message List